0005, reagents

Ended Awarded Last action

Contract number
W81K0216F0081
Awardee
Awarding agency
Obligated
$562,437

Award facts

Opportunity
Contract value 100% obligated
$562,439.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Terminate for Convenience P00015 · Deob FY18 funds $37,867
Supplemental Agreement for work within scope P00014 · Blood gas analyzer and various reagents $0
Supplemental Agreement for work within scope P00013 · Increase contract funding. This requirement is for the (2) cobas B221 chemistry analyzers and reagents. $61,000
Funding Only Action P00012 · 3005, reagents $78,314
Supplemental Agreement for work within scope P00011 · 889 action - 3005, reagents $0
Supplemental Agreement for work within scope P00010 · 3005, reagents $36,000
Exercise an Option P00009 $0
Funding Only Action P00008 · 2005, various reagents $78,314
Change Order P00007 · Various reagents $36,000
Exercise an Option P00006 · Lease of cobas B221 analyzers $0
Funding Only Action P00005 $78,314
Exercise an Option P00004 $0
Funding Only Action P00003 $78,314
Exercise an Option P00002 $0
Funding Only Action P00001 $78,314
Original award $0
Show all 16

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $562,439 delivery order against Roche Diagnostics Corporation's GSA Schedule contract for in vitro diagnostics, reagents, and tests. The five-year order calls for Roche to provide reagents to Madigan Army Medical Center to support the Army medical facility's testing needs. As the prime contractor, Roche will fulfill the requirements for item 0005, delivering the necessary reagents. The contract was awarded on a firm-fixed price basis and represents a task order under Roche's master agreement held under GSA Schedule 65-VII. Performance will take place at Madigan Army Medical Center in Washington.

Quick answers

Who was awarded contract W81K0216F0081?

W81K0216F0081 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on September 29, 2016.

How much is contract W81K0216F0081 worth?

The government has obligated $562,437 on W81K0216F0081. Its current value, with exercised options, is $562,439.

Is contract W81K0216F0081 an order under another contract?

Yes. W81K0216F0081 is a delivery order under V797P5279B, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract W81K0216F0081 competed?

The extent of competition for W81K0216F0081 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login